Cellebrite Other Stockholder Equity from 2010 to 2024

CLBT Stock  USD 19.99  0.27  1.37%   
Cellebrite Other Stockholder Equity yearly trend continues to be comparatively stable with very little volatility. Other Stockholder Equity will likely drop to about -89.2 M in 2024. From the period from 2010 to 2024, Cellebrite Other Stockholder Equity quarterly data regression had mean square error of 448.6 T and mean deviation of  15,011,179. View All Fundamentals
 
Other Stockholder Equity  
First Reported
2010-12-31
Previous Quarter
-85 M
Current Value
-89.2 M
Quarterly Volatility
23.1 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Cellebrite financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Cellebrite's main balance sheet or income statement drivers, such as Tax Provision of 4 M, Interest Income of 8.4 M or Depreciation And Amortization of 8 M, as well as many indicators such as Price To Sales Ratio of 6.58, Dividend Yield of 0.0818 or PTB Ratio of 50.54. Cellebrite financial statements analysis is a perfect complement when working with Cellebrite Valuation or Volatility modules.
  
Check out the analysis of Cellebrite Correlation against competitors.

Latest Cellebrite's Other Stockholder Equity Growth Pattern

Below is the plot of the Other Stockholder Equity of Cellebrite DI over the last few years. It is Cellebrite's Other Stockholder Equity historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Cellebrite's overall financial position and show how it may be relating to other accounts over time.
Other Stockholder Equity10 Years Trend
Slightly volatile
   Other Stockholder Equity   
       Timeline  

Cellebrite Other Stockholder Equity Regression Statistics

Arithmetic Mean(85,170,737)
Coefficient Of Variation(27.17)
Mean Deviation15,011,179
Median(75,742,000)
Standard Deviation23,143,746
Sample Variance535.6T
Range86.1M
R-Value(0.47)
Mean Square Error448.6T
R-Squared0.22
Significance0.08
Slope(2,440,398)
Total Sum of Squares7498.9T

Cellebrite Other Stockholder Equity History

2024-89.2 M
2023-85 M
2022-125.7 M
2021-153.2 M
2020-67.1 M

About Cellebrite Financial Statements

Cellebrite shareholders use historical fundamental indicators, such as Other Stockholder Equity, to determine how well the company is positioned to perform in the future. Although Cellebrite investors may analyze each financial statement separately, they are all interrelated. The changes in Cellebrite's assets and liabilities, for example, are also reflected in the revenues and expenses on on Cellebrite's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Other Stockholder Equity-85 M-89.2 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Cellebrite Stock Analysis

When running Cellebrite's price analysis, check to measure Cellebrite's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cellebrite is operating at the current time. Most of Cellebrite's value examination focuses on studying past and present price action to predict the probability of Cellebrite's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cellebrite's price. Additionally, you may evaluate how the addition of Cellebrite to your portfolios can decrease your overall portfolio volatility.